| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $101.03M | - | |
| Dir | 1.55M | $79.87M | - | |
| Dir | 1.19M | $61.15M | - | |
| CFO | 1.12M | $57.45M | - | |
| VP | 594.7K | $30.58M | -43,451 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2021 | Poste George | Director | Sell | 40,802 | $24.97 | $1,018,825.94 | -20.6% | -29.7% | -21.4% | |
| May 14, 2021 | Marchesi Vincent T | Director | Sale+OE | 40,000 | $25.04 | $1,001,600.00 | -37.7% | -29.7% | -21.4% | |
| May 13, 2021 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 100,000 | $25.38 | $2,538,000.00 | -14.0% | -31.4% | -21.1% | |
| May 11, 2021 | Freire Maria C54 | Director | Sell | 8,275 | $25.01 | $206,957.75 | -20.6% | -28.9% | -19.6% | |
| May 11, 2021 | Papadopoulos Stelios53 | Director | Sale+OE | 20,770 | $24.98 | $518,793.63 | -0.5% | -28.9% | -19.6% | |
| Apr 26, 2021 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 50,000 | $25.00 | $1,250,000.00 | -7.5% | -33.6% | -10.5% | |
| Apr 26, 2021 | Haley Patrick J.56 | EVP, Commercial | Sell | 7,665 | $25.03 | $191,854.95 | -2.5% | -33.6% | -10.5% | |
| Apr 26, 2021 | Hessekiel Jeffrey54 | EVP And General Counsel | Sell | 18,000 | $25.03 | $450,540.00 | -2.8% | -33.6% | -10.5% | |
| Apr 1, 2021 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 60,000 | $22.96 | $1,377,600.00 | -13.3% | -21.2% | -1.0% | |
| Apr 1, 2021 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 50,000 | $23.00 | $1,150,000.00 | -7.5% | -21.2% | -1.0% |